279 filings
Page 5 of 14
8-K
0pjox8gv4o3s8q6
23 Feb 21
Epizyme Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
6:50am
8-K
ax9w87i6j30mcp
23 Dec 20
Termination of a Material Definitive Agreement
4:17pm
8-K
61xq7drnkzw11veku2
6 Nov 20
Epizyme Reports Business Progress and Third Quarter 2020 Financial Results
6:47am
8-K
v43wxk 7e
4 Aug 20
Epizyme Reports Business Progress and Second Quarter 2020 Financial Results
6:52am
8-K
hcy1968oyr16i 8r
3 Jun 20
Submission of Matters to a Vote of Security Holders
7:52am
8-K
kk2uhkm8vl vr
4 May 20
Epizyme Reports Business Progress and First Quarter 2020 Financial Results
6:42am
DEFA14A
onif6q5diw4mt jo4fi
17 Apr 20
Additional proxy soliciting materials
2:05pm
PRE 14A
upocem2
6 Apr 20
Preliminary proxy
9:46pm
8-K
x6z0dz7
3 Apr 20
Departure of Directors or Certain Officers
4:05pm
S-8
p6siaf
27 Feb 20
Registration of securities for employees
12:00am
8-K
5c4q wzslz4
24 Feb 20
Epizyme Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial Results
6:41am
SEC STAFF
2lbbuc5x
18 Feb 20
SEC staff action: Order
12:00am
SEC STAFF
8wpre680
6 Feb 20
SEC staff action: Order
12:00am
8-K
9bz88dyl
6 Jan 20
Epizyme Announces Exercise of $50 Million Option with Royalty Pharma and Highlights Key 2020 Initiatives to Build Long-Term Value
6:38am
8-K
yohf918s 9vj
4 Nov 19
Entry into a Material Definitive Agreement
7:11am